Aplastic anemia: the correct nomenclature matters

Aplastic anemia.

PURPOSE OF REVIEW Most acquired aplastic anemia is the result of immune-mediated destruction of hematopoietic stem cells causing pancytopenia and an empty bone marrow, which can be successfully treated with either immunosuppressive therapy or hematopoietic stem-cell transplantation. RECENT FINDINGS In aplastic anemia, oligoclonally expanded cytotoxic T cells induce apoptosis of hematopoietic ...

ALLOGENIC BONE MARROW TRANSPLANTATION IN APLASTIC ANEMIA

Eighteen patients, twelve men and six women, with aplastic anemia underwent allogenic bone marrow transplantation (BMT) from HLA-matched siblings during the period of 1990 to 1996. The conditioning regimen was cyclophosphamide with or without busulfan, depending on the cause of aplasia. Antilymphocyte globulin (ALG) and cyclosporine were used for rejection and acute GVHD prophylaxis, respe...

Attitudinally correct nomenclature.

Aplastic Anemia - Diagnos tics and Therapy of Acquired Aplastic Anemia

Probiotic nomenclature matters

Probiotic research has progressed greatly in recent years, to the extent that full genomic sequencing is becoming commonplace for strains used in intervention trials. Unfortunately, examples of inaccurate nomenclature or incomplete taxonomic description of probiotic strains still occurs in the scientific database. One recent example is a publication by Han and colleagues. In this paper, the nam...